Analyst Reco. Ventyx Biosciences, Inc.

Equities

VTYX

US92332V1070

Market Closed - Nasdaq Other stock markets 21:00:00 18/06/2024 BST			5-day change	1st Jan Change
2.75 ^USD	0.00%		-7.72%	+11.34%

06-11	Transcript : Ventyx Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 08:40 AM
06-06	Oppenheimer Adjusts Ventyx Biosciences Price Target to $10 From $12, Maintains Outperform Rating	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oppenheimer Adjusts Ventyx Biosciences Price Target to $10 From $12, Maintains Outperform Rating	06-06	MT
Canaccord Genuity Trims Price Target on Ventyx Biosciences to $15 From $16, Maintains Buy Rating	03-13	MT
Oppenheimer Upgrades Ventyx Biosciences to Outperform From Perform, $12 Price Target	03-12	MT
Wells Fargo Upgrades Ventyx Biosciences to Overweight From Equal Weight, Raises Price Target to $16 From $7	03-12	MT
Canaccord Genuity Adjusts Ventyx Biosciences' Price Target to $16 From $20, Maintains Buy Rating	03-11	MT
Lifesci Capital Upgrades Ventyx Biosciences to Outperform From Market Perform, $5 Price Target	02-28	MT
Wells Fargo Cuts Ventyx Biosciences Price Target to $3 From $8, Maintains Equal Weight Rating	12-19	MT
Stifel Adjusts Price Target on Ventyx Biosciences to $2 From $6, Maintains Hold Rating	12-18	MT
HC Wainwright Downgrades Ventyx Biosciences to Neutral From Buy	11-07	MT
Stifel Downgrades Ventyx Biosciences to Hold From Buy, Cuts Price Target to $6 From $56	11-07	MT
Oppenheimer Downgrades Ventyx Biosciences to Perform From Outperform, Removes $56 Price Target	11-07	MT
Evercore ISI Lowers Ventyx Biosciences' Price Target to $47 From $65, Maintains Outperform Rating	10/10/23	MT
Oppenheimer Adjusts Ventyx Biosciences Price Target to $56 From $57, Maintains Outperform Rating	10/10/23	MT
Morgan Stanley Adjusts Price Target on Ventyx Biosciences to $46 From $45, Maintains Overweight Rating	29/08/23	MT
Credit Suisse Adjusts Ventyx Biosciences' Price Target to $62 From $63, Keeps Outperform Rating	11/08/23	MT
Oppenheimer Adjusts Ventyx Biosciences Price Target to $57 From $62, Maintains Outperform Rating	11/08/23	MT
HC Wainwright Adjusts Price Target on Ventyx Biosciences to $52 From $54, Maintains Buy Rating	11/08/23	MT
HC Wainwright Raises Ventyx Biosciences' Price Target to $54 From $50, Buy Rating Kept	12/05/23	MT
Oppenheimer Adjusts Ventyx Biosciences Price Target to $62 From $65, Maintains Outperform Rating	24/03/23	MT
Wells Fargo Starts Ventyx Biosciences at Overweight With $77 Price Target	21/03/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Ventyx Biosciences, Inc.

Equities

VTYX

US92332V1070

Analyst Reco.

Filters